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Calcium oxalate crystals
induce renal inflammation by
NLRP3-mediated IL-1β secretion
Shrikant R. Mulay,1 Onkar P. Kulkarni,1 Khader V. Rupanagudi,1 Adriana Migliorini,1
Murthy N. Darisipudi,1 Akosua Vilaysane,2 Daniel Muruve,2 Yan Shi,3
Fay Munro,3 Helen Liapis,4 and Hans-Joachim Anders1
1Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany. 2Department of Medicine,
Division of Nephrology and Hypertension, Department of Medicine and the Immunology Research Group, Institute of Infection, Immunity and Inflammation,
and 3Department of Medicine, Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
4Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.

Nephrocalcinosis, acute calcium oxalate (CaOx) nephropathy, and renal stone disease can lead to inflammation and subsequent renal failure, but the underlying pathological mechanisms remain elusive. Other crystallopathies, such as gout, atherosclerosis, and asbestosis, trigger inflammation and tissue remodeling by inducing IL-1β secretion, leading us to hypothesize that CaOx crystals may induce inflammation in a similar manner.
In mice, intrarenal CaOx deposition induced tubular damage, cytokine expression, neutrophil recruitment,
and renal failure. We found that CaOx crystals activated murine renal DCs to secrete IL-1β through a pathway
that included NLRP3, ASC, and caspase-1. Despite a similar amount of crystal deposits, intrarenal inflammation, tubular damage, and renal dysfunction were abrogated in mice deficient in MyD88; NLRP3, ASC, and
caspase-1; IL-1R; or IL-18. Nephropathy was attenuated by DC depletion, ATP depletion, or therapeutic IL-1
antagonism. These data demonstrated that CaOx crystals trigger IL-1β–dependent innate immunity via the
NLRP3/ASC/caspase-1 axis in intrarenal mononuclear phagocytes and directly damage tubular cells, leading
to the release of the NLRP3 agonist ATP. Furthermore, these results suggest that IL-1β blockade may prevent
renal damage in nephrocalcinosis.
Introduction
Kidney stone disease affects about 12% of men and 5% of women
during their lifetimes in the United States (1). Unlike symptomatic
urolithiasis, intrarenal nephrocalcinosis is often asymptomatic, but
can lead to significant kidney injury and renal failure (1–3). Calcium oxalate (CaOx) stones account for the vast majority of calculi
in primary and secondary forms of hyperoxaluria (4, 5). In addition,
acute oxalosis (e.g., in ethylene glycol poisoning) can induce acute
kidney injury as a result of widespread intrarenal CaOx deposition (6). Histopathology of human CaOx nephropathy as well as
microarray analysis of rodent CaOx nephropathy document a substantial contribution of interstitial inflammation to tissue remodeling, but the molecular and cellular mechanisms of CaOx-induced
renal inflammation remain largely unknown (7–11).
Inflammation and tissue remodeling in various crystallopathies,
such as gout (caused by monosodium urate crystals), pseudogout
(caused by calcium pyrophosphate crystals; ref. 12); atherosclerosis (caused by cholesterol crystals; ref. 13) silicosis (caused by
silica crystals; ref. 14) and asbestosis (caused by asbestos; ref. 14),
involve a unique intracellular signaling pathway for the secretion
of the proinflammatory cytokine IL-1β: the NLRP3 inflammasome/apoptosis-associated speck-like protein containing CARD/
caspase-1 (NLRP3/ASC/caspase-1) axis (15). The NLRP3 inflammasome is a large cytoplasmatic protein complex able to integrate
multiple extracellular and intracellular danger signals into ASC
binding and activation of caspase-1 (also known as pro–IL-1β conConflict of interest: The authors have declared that no conflict of interest exists.
Citation for this article: J Clin Invest. 2013;123(1):236–246. doi:10.1172/JCI63679.
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verting enzyme; ref. 15). In contrast to other NF-κB–dependent
cytokines that are readily secreted, the inactive pro-form of IL-1β
requires cleavage (e.g., by caspase-1) as an additional enzymatic step
before the bioactive form of IL-1β can be secreted from the cell (15).
Here, we hypothesized that CaOx crystals have a similar agonistic potential on NLRP3 and trigger IL-1β secretion and that this
process contributes to CaOx-induced tissue inflammation, for
example, in nephrocalcinosis and/or CaOx nephropathy.
Results
CaOx crystals need NLRP3/ASC/caspase-1 to induce IL-1β in DCs. We
hypothesized that CaOx crystals have the same potential to activate DCs as do crystals of uric acid, calcium pyrophosphate, or
cholesterol (12, 13). CaOx crystals were of small size when used
in vitro together with bone marrow–derived DCs (BMDCs; Supplemental Figure 1; supplemental material available online with
this article; doi:10.1172/JCI63679DS1). CaOx crystal exposure
activated murine BMDCs to release IL-1β in a dose-dependent
manner, but only when cells were prestimulated with LPS, TNF,
IL-1α, or histones (Figure 1A and Supplemental Figure 2). Western blotting of DC supernatants revealed that LPS prestimulation
was a prerequisite for induction of pro–IL-1β expression (Figure
1A). LPS also induced pro–caspase-1 in BMDCs, and CaOx crystals induced caspase-1 activation similar to that by the NLRP3
agonist ATP (Figure 1A). To address a potential NLRP3 agonistic
effect of CaOx crystals, BMDCs from Nlrp3–/–, Asc–/–, and Casp1–/–
mice were also prepared; LPS/CaOx crystals were unable to induce
IL-1β secretion in these cells (Figure 1, B and C). Although LPS
induced pro–IL-1β and pro–caspase-1 expression, CaOX crystals
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Figure 1
CaOx crystals activate DCs to secrete
mature IL-1β. (A) WT BMDCs were stimulated with increasing doses of CaOx crystals
with or without LPS prestimulation (1 μg/ml),
and IL-1β secretion was measured by ELISA.
ATP served as a positive control of NLRP3
activation. Western blotting of supernatants
showed induction of pro–IL-1β by LPS; only
CaOx crystals and ATP induced mature IL-1β
secretion. This process involved caspase-1
activation (cleavage product, 10 kDa). (B)
DCs from WT, Nlrp3 –/– , and Asc –/– mice.
CaOx crystal– and ATP-induced IL-1β secretion depended on the presence of NLRP3
and ASC regardless of pro–IL-1β induction.
(C) Similar results were obtained in DCs
isolated from Casp1–/– mice. (D) WT BMDCs
were stimulated with LPS/CaOx with or without the caspase inhibitor Z-VAD-FMK. Data
are means ± SD from 3 separate experiments. *P < 0.05 vs. medium; ***P < 0.001
vs. respective WT (B and C) or PBS (D).

were unable to induce caspase-1 activation in Nlrp3–/–, Asc–/–, and
Casp1–/– BMDCs, as was the case with LPS/ATP stimulation (Figure 1, B and C). Additionally, the caspase inhibitor Z-VAD-FMK
had the same effect on LPS/CaOx crystal–induced IL-1β secretion
in BMDCs (Figure 1D). Thus, CaOx crystals induced IL-1β secretion in DCs via the NLRP3/ASC/caspase-1 axis.
CaOx crystal–induced NLRP3 activation depends on phagocytosis and
potassium efflux. Whether agonists directly interact with NLRP3
remains unknown, but various mechanisms are involved in NLRP3
activation by extracellular danger signals: particle uptake into
the cell by phagocytosis, lysosomal cathepsin leakage, potassium
efflux from the cell, P2X7 channel activation, and intracellular oxidative stress (15). We therefore performed a series of experiments
to determine which of the aforementioned factors contributes
to CaOx crystal–induced NLRP3 activation. Cytochalasin D, a
phagocytosis-blocking agent that inhibited actin polymerization
and crystal uptake into intracellular endosomes (Figure 2A), significantly reduced LPS/CaOx crystal–induced IL-1β secretion in
BMDCs, whereas the cathepsin inhibitor CA074Me and the antioxidant N-acetyl cysteine had no effect (Figure 2B). Furthermore,
blocking potassium efflux by a high concentration of potassium in
the extracellular fluid had the same effect (Figure 2C), which suggests that potassium efflux is required for CaOx-induced NLRP3
activation. Comparison of LPS/CaOx crystal–induced IL-1β secretion between WT and P2x7–/– BMDCs did not support a contri-

bution of P2X7 in this context (Figure 2D). Thus, CaOx crystals
induced NLRP3-mediated IL-1β secretion in DCs via phagocytic
uptake of CaOx crystals into intracellular endosomes as well as
via inducing potassium efflux from the cell, a process known to
activate NLRP3 (16).
CaOx crystals induce IL-1β secretion in renal DCs, but not in renal
parenchymal cells. To determine whether CaOx crystals have a similar potential to activate renal DCs or renal parenchymal cells, we
stimulated primary renal CD45+CD11c+ DCs, ECs, mesangial cells
(MCs), and tubular epithelial cells (TECs) with LPS/CaOx crystals
as above. LPS/CaOx crystals induced IL-1β secretion in renal DCs
in a manner similar to that of LPS/ATP, whereas none of the renal
parenchymal cell types responded to the stimulation (Figure 2E).
Western blotting confirmed this finding and also showed that LPS
stimulation only induced pro–IL-1β expression in renal DCs (Figure 2F). Hence, CaOx crystals induced secretion of mature IL-1β
only in renal DCs, not in renal parenchymal cells.
CaOx crystals induce ATP release from dying TECs. Consistent with
previous reports (10), CaOx crystal exposure killed TECs (as
demonstrated by lactate dehydrogenase [LDH] release) in a dosedependent manner, independent of Nlrp3 genotype (Supplemental Figure 3). Dying cells release intracellular damage-associated
molecular pattern molecules (DAMPs) that have the potential to
activate pattern recognition receptors of other cells (17). ATP is
one such intracellular DAMP, reported to drive sterile inflamma-
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Figure 2
Mechanisms of CaOx crystal–induced IL-1β secretion. (A) BMDCs were primed with LPS (1 μg/ml) and stimulated with CaOx crystals in the presence or absence of cytochalasin D. TEM showed that CaOx crystals appeared outside the cell (asterisks) and inside intracellular endosomes
(arrowheads), whereas cytochalasin D treatment inhibited their uptake in DCs. (B) Incubation with cytochalasin D, CA074Me, and N-acetyl cysteine
(NAC) affected IL-1β secretion, measured by ELISA in cell culture supernatants after 6 hours. (C) Similar experiments were performed using 75 mM
KCl in cell culture medium to block potassium efflux from the DCs. NaCl of an identical molarity was used as a molarity control. High extracellular
potassium prevented CaOx-induced IL-1β secretion. (D) DCs were isolated from WT and P2x7–/– mice. ATP-induced, but not CaOx-induced, IL-1β
secretion depended on the presence of P2X7. Data are means ± SD from 3 independent experiments. (E) Renal ECs, MCs, TECs, and renal DCs
were primed with LPS and exposed to CaOx crystals, and IL-1β secretion was measured. ATP was used as a positive control for NLRP3 activation. (F) Western blotting. LPS priming induced pro–IL-1β expression only in DCs. (G) Primary TECs were isolated from WT mice and cultured with
increasing concentrations of CaOx. ATP release was quantified in cell culture supernatant upon 18 hours of CaOx crystal exposure with and without
increasing concentrations of apyrase. (H) Coculture of LPS-primed DCs with CaOx (100 μg/ml) damaged TECs with or without apyrase (1 U/ml).
IL-1β secretion was measured by ELISA after 24 hours. Data are means ± SD from 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001
vs. medium (B, C, and E); vs. WT (D); vs. 1,000 μg/ml CaOx alone (G); or as indicated by brackets.
238
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Figure 3
CaOx nephropathy in C57BL/6 mice. (A) Kidney sections showed CaOx
crystals distributed throughout, especially in the tubular lumina (Pizzolato stain; left) or viewed under polarized light (right). Original magnification, ×100 (left); ×200 (right); ×400 (inset). (B) At higher magnification,
Pizzolato stain showed smaller (granular) crystals inside TECs as well
as in the renal interstitial compartment. Original magnification, ×400
(left), ×1,000 (right). (C) TEM (left) confirmed large CaOx crystal aggregates within the tubular lumen (black arrow) as well as in the interstitial
space (white arrow). Freeze-fracture EM (right) identified CaOx crystals
in the tubular lumen (black arrow) as well as inside cytoplasmic organelles, some of which appeared to be lysosomes (white arrows). Original
magnification, ×3,000. (D) TEM also showed CaOx crystals within the
interstitial compartment in close proximity to interstitial cells (left; black
arrows). At higher magnification (right), an interstitial cell (white asterisk
indicates nucleus) engulfed a CaOx crystal (black arrows denote outer
cell membrane); neighboring TECs are denoted by black asterisks.
Original magnification, ×7,000 (left); ×25,000 (right).

tion upon cell death via activation of NLRP3 (18, 19). Thus, we
tested whether CaOx crystal–induced death of cultured TECs is
associated with marked ATP release. In fact, CaOx crystal exposure induced ATP concentrations in cell culture supernatants in
a dose-dependent manner (Figure 2G). In addition, extracellular
ATP levels were readily degraded by adding apyrase at concentrations of 0.25 U/ml or higher (Figure 2G). Accordingly, coculture
of BMDCs with CaOx-damaged primary tubular cells — with or
without apyrase treatment — significantly reduced their capacity
to secrete IL-1β (Figure 2H). Thus, CaOx crystals activated and
destabilized TECs, a process that promoted the release of ATP,
which activated DCs to release IL-1β.
Oxalate nephropathy involves diffuse crystal deposition, renal inflammation, and failure. Given the potential of CaOx crystals to activate
renal DCs via NLRP3/ASC/caspase-1 in both direct and indirect
ways, we suspected they make a functional contribution to oxalate nephropathy. Direct DC activation would require CaOx crystals to also reach the renal interstitial compartment, where DCs
and other antigen-presenting cells span a dense network around
the tubules (20). Murine oxalate nephropathy was characterized
by diffuse CaOx crystal deposition throughout the kidney, with
focal crystal casts obstructing proximal and distal tubules within

the outer medulla as well as within the cortex, which was absent
in control mice (Figure 3A and Supplemental Figure 4). Single
crystals or small clumps of crystals, similar in appearance to the
ones we applied for cell culture (Supplemental Figure 1), not only
adhered to the luminal membranes of TECs, but were also found
intracellularly within endosomes (Figure 3, B and C, and Supplemental Figure 5A). Diffuse CaOx crystal deposits were also found
in the renal interstitial compartment, in close proximity to and
within renal interstitial cells (Figure 3, B and D, and Supplemental
Figure 5B). In fact, transmission EM (TEM) imaging showed that
interstitial cells occasionally engulfed and took up crystals (Figure
3D). Renal CaOx crystal deposition was associated with diffuse
neutrophil infiltrates and tubular necrosis mainly at the inner
stripe of the outer medulla, as demonstrated by the disintegration
of TECs and granular casts in tubular lumen (Figure 4, A and B).
The structural alterations of oxalate nephropathy were associated
with renal failure, as shown by a transient increase in plasma creatinine and BUN levels, peaking at 24 hours, compared with those in
vehicle-injected mice (Figure 4A and Supplemental Figure 6). Intrarenal mRNA expression of the kidney injury markers KIM-1 and
L-FABP, as well as that of the proinflammatory cytokines IL-6 and
TNF-α, was increased (Figure 4C). Together, these observations
indicated that murine oxalate nephropathy was characterized by
diffuse CaOx crystal formation inside the tubular and the interstitial compartments, which is associated with tubular injury, renal
inflammation, and failure.
Oxalate nephropathy depends on MyD88, IL-1R, and IL-18. Cytokine
expression and neutrophil infiltration are suggestive of the
involvement of innate immunity in oxalate nephropathy. To test
this concept, we induced oxalate nephropathy in Myd88–/– mice,
since MyD88 is a central signaling adaptor that translates innate
pattern recognition into NF-κB activation and expression of proinflammatory cytokines, including pro–IL-1β and pro–IL-18 (21,
22). Unlike WT mice, Myd88–/– mice were almost entirely protected
from acute kidney injury and failure, despite harboring identical
CaOx crystal depositions (Figure 5). Il1r–/– mice were almost entirely protected, whereas Il18–/– mice displayed only partial protection
(Figure 5). Thus, oxalate nephropathy depended on MyD88-mediated innate immunity, which also involved IL-1R and IL-18.
Oxalate nephropathy is abrogated in Nlrp3–/–, Asc–/–, and Casp1–/– mice.
To test the functional contribution of the NLRP3/ASC/caspase-1
axis, we induced oxalate nephropathy in Nlrp3–/–, Asc–/–, or Casp1–/–
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Figure 4
Oxalate nephropathy in C57BL/6 mice. (A) Oxalate feeding caused diffuse oxalate deposition within 24 hours and
significantly increased plasma creatinine levels and BUN
levels. (B) PAS staining illustrated tubular necrosis, which
was quantified by semiquantitative scoring (loss of brush
border, flattening of cells, disruption and detachment of
tubular cells from basement membranes). Renal neutrophil counts were determined by Ly6G B1.2 immunostaining
and quantified per 15 hpfs. Original magnification, ×100.
(C) Renal mRNA expression was determined by real-time
RT-PCR. Data are means ± SEM from 5–6 mice per group.
*P < 0.05, ***P < 0.001.

mice. Despite renal CaOx deposits identical to those of WT controls, all 3 groups were partially protected from kidney injury and
failure, as evidenced by significant reductions in plasma creatinine, BUN, tubular damage, mRNA expression of tubular injury
markers KIM-1 and L-FABP, and interstitial neutrophil infiltrates
(Figure 6 and Supplemental Figure 7). Hence, NLRP3, ASC, and
caspase-1 contributed to renal inflammation, damage, and dysfunction in CaOx nephropathy.
CaOx crystal–induced acute kidney injury depends on intrarenal
mononuclear phagocytes. The results of our in vitro studies suggested that CaOx crystal–induced IL-1β secretion may selectively originate from the intrarenal network of mononuclear
phagocytes, such as DCs and macrophages. Flow cytometry of
renal cell suspension obtained after 24 hours of CaOx exposure
revealed activation of CD45+CD11c+ intrarenal myeloid DCs, as
evidenced by increased surface expression of CD40 and CD86
as well as by protrusions and dendrite expansion, visualized by
scanning EM (Figure 7, A and B, and Supplemental Figure 8A).
Next, we depleted monocytic phagocytes from the kidney by
2 injections of clodronate liposomes before inducing oxalate
nephropathy. Depletion of CD11c + cells was confirmed by flow
cytometry of renal cell suspensions (Supplemental Figure 8B).
This procedure reduced intrarenal IL-1β production, as determined by ELISA from kidney homogenates (Supplemental Figure 8C). This was associated with partial protection from acute
240

kidney injury compared with control liposome–treated mice (despite identical amounts of CaOx deposits), as documented by a significant reduction of
plasma creatinine level, BUN level, and tubular damage (Figure 7C). Similar results were obtained when
cells were selectively depleted by diphtheria toxin in
CD11c DTRg mice (Figure 7D and Supplemental
Figure 8, B and C). Thus, intrarenal mononuclear
phagocytes mediated cytokine signaling and subsequent renal inflammation, injury, and failure in oxalate nephropathy.
Degradation of extracellular ATP with apyrase protects
mice from oxalate nephropathy. Our in vitro studies
showed that dying TECs released ATP, an endogenous
NLRP3 agonist that triggers IL-1β secretion in DCs
(19). Apyrase injection degrades extracellular ATP and
can block the NLRP3-agonistic effect of this endogenous danger signal during sterile inflammation (18).
We therefore used apyrase injections to test whether
extracellular ATP also contributes to renal inflammation and injury during oxalate nephropathy. A single
intraperitoneal injection of 20 U apyrase partially reduced tubular injury and neutrophil recruitment during oxalate nephropathy and improved renal excretory function, as documented by a
significant reduction of plasma creatinine and BUN levels compared with vehicle-treated control mice (Figure 8A). Systemic
IL-6 and MCP-1 levels were also reduced (Supplemental Figure
9A). We concluded that extracellular ATP (e.g., as it is released
from dying TECs) served as an additional trigger for renal
inflammation and dysfunction in oxalate nephropathy.
The recombinant IL-1R antagonist anakinra prevents oxalate
nephropathy. All of the above observations suggested a functional role of NLRP3/ASC/caspase-1–mediated IL-1β secretion
as a previously unrecognized pathomechanism for inflammation and tissue damage in CaOx nephropathy. Thus, therapeutic
blockade of IL-1β may be able to interfere with this pathomechanism and protect against renal failure. Anakinra, a recombinant
version of the endogenous IL-1 receptor antagonist, is approved
by the FDA for the treatment of rheumatoid arthritis (23, 24).
Intraperitoneal injection of anakinra dose-dependently reduced
tubular injury and neutrophil recruitment and improved renal
excretory function during oxalate nephropathy (Figure 8B and
Supplemental Figure 9B). We concluded that IL-1β mediated
inflammation and tissue damage in kidney injury induced by
CaOx crystals, and thus IL-1 blockade protected from renal failure in oxalate nephropathy.
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Figure 5
Role of MyD88, IL-1R, and IL-18 in CaOx nephropathy. (A) Oxalate deposition was similar in Myd88–/–, Il1r–/–, and Il18–/– mice, but plasma
creatinine levels and BUN were not significantly increased, suggesting a protective role of these molecules in CaOX-induced renal damage. (B) PAS staining illustrated tubular necrosis. Original magnification, ×100. (C) Tubular injury score was determined by semiquantitative
scoring, and renal neutrophil counts were determined by immunostaining and quantified per hpf. Data are means ± SEM from 5–6 mice per
group. *P < 0.05, **P < 0.01, ***P < 0.001.

Discussion
Renal stone disease is widely considered to be a mechanical problem causing intra- or extrarenal urinary outflow obstruction, but
crystal nephropathies are also associated with significant intrarenal inflammation that can cause acute kidney injury (3, 11). We
hypothesized that the NLRP3 inflammasome — an intracellular
pattern recognition platform that translates danger signaling into
secretion of mature IL-1β — is involved in this process, because
immune recognition of numerous crystals involves the NLRP3/
ASC/caspase-1 axis (12–14).
In contrast to widely expressed Toll-like receptors or Rig-like
helicases, the NLRP3/ASC/caspase-1 axis is restricted to antigenpresenting cells inside the kidney (25–27). We used clodronate
liposome in WT mice or diphtheria toxin in CD11c DTRg mice
to demonstrate that CaOx-induced intrarenal IL-1β secretion
originated from the intrarenal network of interstitial mononuclear
phagocytes, which includes several DC populations (28). CaOx crystals also formed in the interstitial compartment, where they were
internalized by interstitial cells, a process demonstrated by us and
others using TEM (present study and ref. 11). Our in vitro studies
confirmed that phagocytic uptake was required for CaOx-induced
IL-1β secretion in DCs, an observation consistent with the mode
of NLRP3 activation by monosodium urate and calcium pyrophosphate crystals (12), silica (14), asbestos (14), and cholesterol crystals (13) in other disease contexts. Potassium efflux from the cell,
occurring upon cell membrane disruption or pore formation by
bacterial toxins, is another trigger of NLRP3 activation in DCs (15,
29). CaOx crystal–induced NLRP3 activation also depended on this
mechanism, which was again consistent with previous reports on
crystals of asbestos, monosodium urate (14), silica (30), cholesterol

(31), and calcium phosphate (32). Intrarenal DCs and macrophages
are important regulators of innate immunity and tissue remodeling
in the kidney (28, 33). They express all known pattern recognition
platforms that translate infectious and noninfectious dangers into
local expression of proinflammatory cytokines and chemokines,
causing subsequent immune-mediated pathology in the kidney (28,
33, 34). In addition, renal DCs express numerous negative regulators of innate immunity that limit overshooting renal inflammation and inappropriate kidney injury, e.g., in postischemic tubular
necrosis (35–37). The present study is the first to our knowledge to
demonstrate that acute kidney injury in crystal nephropathy largely
depends on the capacity of intrarenal mononuclear phagocytes to
trigger renal inflammation upon crystal recognition.
TEM and freeze-fracture EM demonstrated crystal uptake into
intracellular compartments of TECs in vivo. TECs express NLRP3
but lack pro–IL-1β induction upon NF-κB priming (26, 38, 39).
Therefore, CaOx crystals did not trigger mature IL-1β secretion in
TECs. However, TECs internalize CaOx crystals, inducing oxidative
stress and tubular cell necrosis (40–42). We confirmed this finding and showed that necrotic tubular cells released ATP, a potent
NLRP3 agonist (19). Iyer et al. recently demonstrated that ATP is
released upon acute tubular necrosis, which triggers NLRP3 activation and renal inflammation, a process that aggravates postischemic acute kidney injury (43). These results were supported by our
present in vitro studies. In addition, the protective effects of apyrase
treatment on CaOx nephropathy supported the functional contribution of ATP to renal inflammation and damage. It is noteworthy that apyrase injections also reduced plasma levels of IL-6 and
MCP-1, implicating some systemic effects, which could be either
causative or secondary for the improvement of the renal phenotype.
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Figure 6
Role of NLRP3, ASC, and caspase-1 in CaOx nephropathy. (A) Nlrp3–/–, Asc–/–, and Casp1–/– mice showed CaOx deposits similar to those of WT
mice, but decreased creatinine levels. (B) PAS staining illustrated reduced tubular necrosis compared with WT. Original magnification, ×100. (C)
Tubular injury score and white cell counts were also reduced compared with WT. Data are means ± SEM from 5–6 mice per group. *P < 0.05,
**P < 0.01, ***P < 0.001.

IL-1 blockade with appropriate antagonists is an established
treatment of IL-1–dependent diseases, such as rheumatoid
arthritis, Still’s disease, and rare hereditary autoinflammatory
disorders (24). Recently, IL-1 blockade also proved effective in
crystal-mediated diseases, such as gout and pseudogout (44, 45).
The dramatic therapeutic effects seem to directly relate to the
fact that NLRP3 translates crystal recognition into IL-1β secretion as a central element of crystal-induced tissue inflammation
and pathology (24). Our data demonstrated a similar therapeutic
effect of the recombinant IL-1 receptor antagonist anakinra in
CaOx nephropathy in mice, which suggests that IL-1 blockade
may also reduce renal inflammation and kidney damage in other
crystal nephropathies.
In conclusion, CaOx crystals triggered IL-1β–dependent innate
immunity via the NLRP3/ASC/caspase-1 axis in DCs. Thus, intrarenal antigen-presenting cells promoted IL-1–dependent inflammation and kidney injury in renal stone disease. In addition, CaOx
crystals indirectly activated NLRP3 by damaging TECs and releasing the NLRP3 agonist ATP. IL-1β blockade with anakinra prevented CaOx kidney injury disease, which could be a novel therapeutic approach to limit kidney damage in crystal nephropathies.
Methods
Animal studies
C57BL/6, NOD/ShiLt, NOD/Casp1–/–, Il1r1–/–, Il18–/–, and Myd88–/– mice
were procured from Jackson Laboratories. Nlrp3–/– and Asc–/– mice were
provided by J. Tschopp (University of Lausanne, Lausanne, Switzerland)
and by V. Dixit (Genentech, San Francisco, California, USA). CD11c
DTRg mice were provided by C. Kurts (University of Bonn, Bonn, Germany) and D. Engel (University of Bonn, Bonn, Germany). Mice were
housed in groups of 5 in filter top cages with unlimited access to food
242

and water. Cages, food, and water were sterilized by autoclaving before
use. 6- to 8-week-old mice received a single intraperitoneal injection of
100 mg/kg sodium oxalate and 3% sodium oxalate in drinking water,
and kidneys were harvested after 24 hours. DC depletion was achieved
by 2 intravenous injections of liposomal clodronate (200 μl) at 48 and 24
hours before injection of sodium oxalate. Control liposomes were used
as vehicle control. In another experiment, CD11c DTRg mice were given
a single intravenous injection of 8 ng diphtheria toxin (Sigma-Aldrich) 6
hours before sacrifice. Urine samples were collected after 24 hours, before
sacrifice by cervical dislocation and harvest of plasma and kidney tissue
(46). Kidneys were kept at –80°C for protein isolation and in RNA later
solution at –20°C for RNA isolation. One part of the kidney was also kept
in formalin to be embedded in paraffin for histological analysis.

Assessment of renal injury
Kidney sections (2 μm) were stained with periodic acid–Schiff (PAS)
reagent. Tubular injury was scored by assessing the percentage of necrotic
tubules and presence of tubular casts. Ly6B.2+ neutrophils were identified by immunostaining (clone 7/4; Serotec). Pizzolato staining visualized
CaOx crystals, and crystal deposit formation in the kidney was evaluated
as described previously (47), using the following point values: 0, no deposits; 1, crystals in papillary tip; 2, crystals in cortical medullary junction; 3,
crystals in cortex. When crystals were observed in multiple areas, points
were combined. Plasma creatinine and BUN were measured using Urea FS
kit (DiaSys Diagnostic Systems) according to the manufacturer’s protocol. Both parameters were corrected for body weight. Neutrophil infiltrates
were counted in 15 high-power fields (hpfs) per section.

EM
Scanning EM. Kidney tissues were rinsed with PBS and postfixed with 1%
aqueous osmium tetroxide for a total of 2.5 hours. Subsequently, tissues
were rinsed and dehydrated through a graded series of ethanol to abso-
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Figure 7
Role of DCs in CaOx nephropathy. CD45+CD11c+ cells were extracted from C57BL/6 by magnetic beads and sorted by flow cytometry using
antibodies for the activation markers CD40 and MHC class II. (A) Percentage of cells with the specific markers. (B) CD45+CD11c+ cells were
examined by scanning EM. DCs from CaOx mice showed marked cell surface disruption compared with the smooth bosselated surface of
control cells. Scale bars: 2.5 μm. (C) CaOx nephropathy was induced in mice depleted of DCs (pretreated with clodronate liposomes) and
compared with that in mice treated with control liposomes. (D) The same analyses were performed in CD11c DTRg mice in which CD11c+
cells were depleted by diphtheria toxin (DT) injection. Data are means ± SEM from 5–6 mice per group. *P < 0.05, **P < 0.01, ***P < 0.001.

lute ethanol and critical-point dried using liquid CO2. After mounting
on stubs, the specimens were sputter-coated with a gold-palladium alloy
for 1.5 minutes. DCs in suspension were rinsed in PBS and centrifuged to
concentrate the cells. Then cells were dropped on coated coverslips and
allowed to adhere; coverslips were fixed as above. Coverslips were cut into
pieces prior to mounting on stubs. Images were viewed with a Hitachi 2600
electron microscope.
TEM. Kidneys were immersed in cold modified Karnovsky fixative containing 3% glutaraldehyde and 1% paraformaldehyde in sodium cacodylate
buffer (pH 7.4) processed as previously described (48). In another set of
experiments, BMDCs were stimulated with 1 μg/ml LPS and 100 μg/ml
CaOx, with or without cytochalasin D pretreatment. After stimulation,
cells were fixed with 2% paraformaldehyde with 2% glutaraldehyde in PBS
buffer (pH 7.4) and processed. The samples were viewed with a JEOL model
1200EX electron microscope.
Quick-freeze deep-etch EM. 1.5-mm bread slices of nonfixed kidney or kidney sections fixed overnight in 2% glutaraldehyde in NaHCa (100 mM
NaCl, 30 mM Hepes, and 2 mM CaCl2, pH 7.2) were used after rinsing in
NaHCa. Tissues were then cooled to 4°K with liquid helium; mounted in
a Balzers 400 vacuum evaporator, fractured, and etched for 2.5 minutes at
–104°C; rotary replicated with approximately 3 nm platinum, as previously
described (49); and viewed using a JEOL 1400 microscope with attached
AMT digital camera.

RNA preparation and real-time quantitative RT-PCR
Total RNA was isolated from kidneys using a Qiagen RNA extraction kit
following the manufacturer’s instructions. After quantification, RNA
quality was assessed using agarose gels. From isolated RNA, cDNA was
prepared using reverse transcriptase (Superscript II; Invitrogen). Real-time
quantitative RT-PCR (TaqMan) was performed using SYBRGreen PCR
master mix and analyzed with a Light Cycler 480 (Roche). All gene expres-

sion values were normalized using 18s RNA as a housekeeping gene. All
primers used for amplification were from Metabion. The expression of
KIM-1, IL-6, and TNF-α was analyzed using the following primers: Kim-1
forward, TCAGCTCGGGAATGCACA; Kim-1 reverse, TGGTTGCCTTCCGTGTCT; L-FABP forward, AGGCAATAGGTCTGCCCGAGGAC;
L-FABP reverse, CCAGTTCGCACTCCTCCCCCA; IL-6 forward, TGATGCACTTGCAGAAAACA; IL-6 reverse, ACCAGAGGAAATTTTCAATAGGC; TNF-α forward, CCACCACGCTCTTCTGTCTAC; TNF-α reverse,
AGGGTCTGGGCCATAGAACT.

Flow cytometry
Anti-mouse CD11c, CD40, CD86, and CD45 antibodies (BD Biosciences — Pharmingen) were used to detect activated DC and leukocyte
populations in kidneys. F4/80, 7/4, and Ly6G antibodies (Abd Serotec)
and CD3, NK1.1, CD11b, and CD103 antibodies (BD Biosciences —
Pharmingen) were used to detect macrophage, neutrophil, T cell, natural
killer cell, and mononuclear phagocyte populations in kidneys. Respective isotype antibodies were used to demonstrate specific staining of cell
populations. Quantification of cell number was achieved using counting beads for FACS (Invitrogen).

Cell culture studies
BMDCs were established as described previously (50). Renal DCs were
isolated from whole kidneys by magnetic bead separation (MACS)
using CD11c MicroBeads (Miltenyi Biotech). The purity of CD11c +
renal cells was confirmed by FACS analysis using anti-CD11c antibody (BD Biosciences — Pharmingen). Cells were stimulated for 3
hours with 1 μg/ml LPS followed by 100 μg/ml CaOx crystals or
stimulated with 5 mM ATP for 6 hours (all Sigma-Aldrich). Cell-free
supernatants were analyzed for cytokine secretion by ELISA (BD Biosciences — Pharmingen) and immunoblot analysis. Primary TECs were
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Figure 8
Apyrase and anakinra treatment in
CaOx nephropathy in C57BL/6 mice.
Oxalate nephropathy was induced in
C57BL/6 mice treated with or without apyrase (A) and anakinra (B),
and oxalate deposition was quantified using Pizzolato stains. Plasma
creatinine levels were determined as
described in Methods. Tubular injury
score was determined by semiquantitative scoring of PAS sections, and
renal neutrophil counts were determined by immunostaining and quantified per hpf. Original magnification,
×100. Data are means ± SEM from 5–6
mice per group. *P < 0.05, **P < 0.01,
***P < 0.001. ND, not done.

isolated from the kidneys and grown on type IV collagen–coated tissue culture plates (Sigma-Aldrich). Primary renal ECs and MCs were
isolated as described previously (26). The isolated primary cells were
confirmed under light microscope and further characterized by FACS,
immunostaining, Western blot, and RT-PCR. Cells were grown to
confluency before use. 1 × 105 cells per well were used. Primary TECs
were maintained in DMEM/F12 (Sigma-Aldrich) containing 10% FCS
(Sigma-Aldrich), 1% penicillin-streptomycin (Sigma-Aldrich), 125 ng/
ml prostaglandin E1 (Calbiochem), 25 ng/ml EGF (Sigma-Aldrich),
1.8 μg/ml l -thyroxine (Sigma-Aldrich), 3.38 ng/ml hydrocortisone
(Sigma-Aldrich), and 2.5 mg/ml insulin–transferrin–sodium selenite
supplement (I-T-SS; Sigma-Aldrich). Primary endothelia and MCs
were maintained in DMEM (Gibco, Invitrogen) plus 10% FCS and
1% penicillin-streptomycin, and primary renal DCs were maintained
in RPMI (Gibco, Invitrogen) and used immediately. All cells were cultured in an incubator at 37°C, 5% CO2. Supernatants were analyzed for
LDH release using the CytoTox 96 Non-Radioactive Cytotoxicity Assay
Kit (Promega) to evaluate cell death, measuring LDH after 18 hours.
244

Results were expressed as percent of positive control. For ATP release,
the system bioluminescence detection kit for ATP measurement was
used (Promega), following the manufacturer’s instructions.

Coculture studies
Briefly, TECs and BMDCs were generated as described above. TECs were
treated with or without 100 μg/ml CaOx for 18 hours, after which the
supernatants were treated with 1 U/ml apyrase (Sigma-Aldrich). Next,
LPS-primed (1 μg/ml) or unprimed BMDCs were cocultured with the
TECs at a 4:1 ratio in RPMI 1640 (Gibco, Invitrogen) supplemented with
10% FBS. After 24 hours of coculture, the supernatants were collected,
centrifuged, and analyzed for IL-1β concentration by ELISA (BD Biosciences — Pharmingen).

Immunoblots
Upon completion of the 6-hour stimulation experiment, supernatants and
cells were collected. Supernatants were concentrated using Amicon Ultra
centrifugal filters (Millipore Billerica) and resolved on 15% SDS polyacryl-

The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 1   January 2013

Downloaded on October 19, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/63679

research article
amide gels. After electrophoresis, proteins were transferred to PVDF membrane. Primary antibodies were goat polyclonal anti–IL-1β (BAF401; R&D
Systems) and rabbit polyclonal anti–caspase-1 (sc-514; Santa Cruz); this
was followed by incubation with secondary antibody anti-biotin or antirabbit IgG labeled with HRP. Immunostained bands were detected using a
chemiluminescence kit (ECL kit).

Statistics
Data are presented as mean ± SEM. Comparison of groups was performed
using ANOVA; post-hoc Bonferroni correction was used for multiple comparisons. A P value less than 0.05 was considered significant.
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